Drug delivery device

Abstract

A drug delivery device for setting and dispensing a dose of a drug is presented having a support body having a first end defining a first opening and a second end defining a second opening and a centered outer indicator ring. A syringe barrel sealed by a stopper is slidably diposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly, wherein the syringe barrel is positioned within the support body. A needle shield is adapted to be coupled to one of the ends of the support body and slidably disposed thereon. An outer body is adapted to be coupled to the other end of the support body and slidably disposed thereon, wherein the outer indicator ring limits the movement of the outer body as well as of the needle shield.

Claims

1. A drug delivery device comprising: a support body having a first end defining a first opening and a second end defining a second opening, the support body configured to retain a syringe barrel sealed by a stopper slidably disposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly; a needle shield configured to be coupled to the support body and slidably disposed thereon, the needle shield comprising a direction indicator; and an outer body configured to be coupled to the support body, wherein the support body comprises a centered outer indicator ring that limits a movement of the outer body.

2. The drug delivery device of claim 1, wherein the needle shield comprises a mating surface to couple to the support body.

3. The drug delivery device of claim 1, further comprising a detent mechanism configured to constrain movement of the needle shield relative to the support body by opposing the movement with a detent force.

4. The drug delivery device of claim 3, wherein the detent mechanism comprises at least one guiding track defined on the support body and at least one retaining clip on the needle shield deflectable by the at least one guiding track, wherein the at least one guiding track is configured such that the retaining clip follows a first path when the needle shield is depressed for needle extension and a different second path when the needle shield is subsequently extended, wherein a non-return catch is arranged for catching the retaining clip at an end of the second path.

5. The drug delivery device of claim 1, wherein the support body comprises a guiding slot disposed within a wall of the support body, the guiding slot configured to guide movement of the needle shield.

6. The drug delivery device of claim 1, wherein the direction indicator is configured to indicate a longitudinal orientation of the drug delivery device.

7. The drug delivery device of claim 1, wherein the needle shield comprises a body section and a cap section, the cap section of the needle shield being rotationally locked to the body section of the needle shield.

8. The drug delivery device of claim 7, wherein the cap section of the needle shield comprises a non-circular cross section configured to engage in a corresponding opening in the body section of the needle shield.

9. A drug delivery device comprising: a support body having a first end defining a first opening and a second end defining a second opening, the support body configured to retain a syringe barrel sealed by a stopper slidably disposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly; a needle shield configured to be coupled to the support body and slidably disposed thereon; a boot remover configured to remove a protective needle boot from a needle, the boot remover comprising a direction indicator; and an outer body configured to be coupled to the support body, wherein the support body comprises a centered outer indicator ring that limits a movement of the outer body.

10. The drug delivery device of claim 9, wherein the boot remover is configured to engage the needle boot by friction or by barbs.

11. The drug delivery device of claim 9, wherein the boot remover comprises a handle to facilitate boot removal.

12. The drug delivery device of claim 11, wherein the needle shield comprises an opening in which the needle boot is positioned, wherein the handle extends from the opening.

13. The drug delivery device of claim 9, wherein the direction indicator is configured to indicate a longitudinal orientation of the drug delivery device.

14. A drug delivery device comprising: a support body having a first end defining a first opening and a second end defining a second opening, the support body configured to retain a syringe barrel sealed by a stopper slidably disposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly; and an outer body configured to be coupled to the support body and slidably disposed thereon, the outer body comprising a direction indicator, wherein the support body comprises a centered outer indicator ring that limits a movement of the outer body.

15. The drug delivery device of claim 14, wherein a portion of the outer body coupled to the support body comprises a radially outwards directed flange.

16. The drug delivery device of claim 14, wherein the direction indicator comprises a profiled cavity or concavity in a surface of the outer body.

17. The drug delivery device of claim 14, further comprising a detent mechanism configured to constrain movement of the outer body relative to the support body by opposing the movement with a detent force.

18. The drug delivery device of claim 14, further comprising the syringe barrel sealed by the stopper and a plunger rod coupled to the stopper, a proximal portion of the plunger rod configured to be coupled to the outer body.

19. The drug delivery device of claim 14, wherein the direction indicator is configured to indicate a longitudinal orientation of the drug delivery device.

Description

BRIEF DESCRIPTION OF THE FIGURES

(1) The present invention will become more fully understood from the detailed description given hereinbelow and the accompanying drawings which are given by way of illustration only, and thus, are not limitive of the present invention, and wherein:

(2) FIG. 1 is a perspective view of a drug delivery device comprising a support body, an outer body and a needle shield,

(3) FIG. 2 is a longitudinal section of the drug delivery device in a first section plane,

(4) FIG. 3 is a longitudinal section of the drug delivery device in a second section plane,

(5) FIG. 4 is an exploded perspective view of the outer body,

(6) FIG. 5 is a longitudinal section of the support body,

(7) FIG. 6 is an exploded perspective view of the needle shield,

(8) FIG. 7 is a lateral view of the drug delivery device prior to an injection,

(9) FIG. 8 is a lateral view of the drug delivery device during needle insertion,

(10) FIG. 9 is a lateral view of the drug delivery device at the end of injection,

(11) FIG. 10 is a lateral view of the drug delivery after needle retraction, and

(12) FIG. 11 is a schematic view of the drug delivery device with a boot remover for removing the protective needle boot prior to an injection.

(13) Corresponding parts are marked with the same reference symbols in all figures.

DETAILED DESCRIPTION

(14) FIG. 1 is a perspective view of a drug delivery device 1 comprising a support body 2, an outer body 3 and a needle shield 4, all of them having an essentially tubular shape. FIG. 2 is a longitudinal section of the drug delivery device 1 in a first section plane. FIG. 3 is another longitudinal section of the drug delivery device 1 in a second section plane approximately 90 offset from the section plane in FIG. 2. A proximal end of the support body 2 is telescoped in the outer body 3 and a distal end of the support body 2 is telescoped in the needle shield 4. A syringe barrel 5 is slidably arranged within the support body 2, the syringe barrel 5 defining an inner cavity for a dose of a drug. A hollow injection needle 6 is arranged on a distal end of the syringe barrel 5. A stopper 7 is slidably arranged within the syringe barrel 5 for sealing its proximal end and for displacing the drug from the syringe barrel 5 through the injection needle 6. A plunger rod 8 is arranged within the outer body 2 for engaging the stopper 7. The plunger rod 8 may be screwed or snapped into the stopper 7. A needle shield spring 9 is arranged for biasing the needle shield 4 in the distal direction D against the support body 2.

(15) FIG. 4 is an exploded perspective view of the outer body 3. The outer body 3 comprises a tubular base section 3.1 and a cap part 3.2 for closing the proximal end of the base section 3.1. The cap part 3.2 is engageable to the base section 3.1 by a snap fit 3.3 (cf. FIG. 3). The base section 3.1 comprises two ribs 3.4 (cf. FIG. 2) extending inwardly from an inner surface of the base section 3.1 on opposite sides for respectively sliding along a guiding slot 2.1 in the support body (cf. FIG. 1). The cap part 3.2 has a central peg 3.5 for engaging the plunger rod 8 when the drug delivery device 1 is assembled. The central peg 3.5 may either abut the plunger rod 8 or be attached to it. The outer body 3 is movable in a distal direction D and in a proximal direction P with respect to the support body 2.

(16) The syringe barrel 5 is inserted into the support body 2. A proximal barrel collar 5.1, sometimes referred to as a finger flange, on the syringe barrel 5 serves for attaching the syringe barrel 5 to the support body 2 by distally abutting an internal rib 2.4 in the support body 2 so that the syringe barrel 5 is fixed towards the distal direction D in its axial position with respect to the support body 2. The syringe barrel 5 is also fixed towards the proximal direction P by two resilient non-return clips 2.5 which are deflected by the barrel collar 5.1 when assembling the syringe barrel 5 into the support body 2 and snap in place once the barrel collar 5.1 has passed them thus facilitating assembly.

(17) FIG. 5 is a longitudinal section of the support body 2. The support body 2 comprises a indicator ring 2.2 in the shape of radially outwards protruding and essentially circumferential rib. The indicator ring 2.2 may cover part of or the whole circumference of the support body 2. The indicator ring 2.2 is arranged to interact with the needle shield 4 so as to limit distal movement of the support body 2 with respect to the needle shield 4. A guiding track 2.3 is arranged in an outer surface of the support body 2 at the distal end for interacting with the needle shield 4 for limiting axial movement of the support body 2 with respect to the needle shield 4. The guiding track 2.3 comprises a distal inclined section 2.3.1, a longitudinal section 2.3.2, a proximal inclined section 2.3.3 and a non-return catch 2.3.4. Near the proximal end of the support body 2 two resilient snap arms 2.6 for interacting with the outer body 3 are arranged. The resilient snap arms 2.6 initially engage the outer body 3 near its distal end in such a manner that the outer body 3 and the support body 2 are axially coupled unless a first detent force is applied, which deforms the resilient snap arms 2.6 so that the outer body 3 decouples from the support body 2 and can move relative to the support body 2 in the distal direction D.

(18) FIG. 6 is an exploded perspective view of the needle shield 4. The needle shield 4 comprises a tubular body section 4.1 and a cap part 4.2 with a central opening 4.3. The cap part 4.2 is engaged to the body section 4.1 by a snap fit 4.4 (cf. FIG. 3) thus preventing relative axial movement. Two resilient retaining clips 4.5 with a respective inward protrusion 4.7 are arranged on the cap part 4.2. The inward protrusions 4.7 engage the guiding track 2.3 in the support body 2 so as to restrict relative axial movement between the needle shield 4 and the support body 2. A protective needle boot (not illustrated) may be positioned in and/or through the central opening 4.3 of the cap part 4.2 before and after an injection. The cap part 4.2 is rotationally locked to the body section 4.1. This may be achieved by the cap part 4.2 having a non-circular, e.g. elliptical cross section engaging in a corresponding opening in the body section 4.1.

(19) FIG. 7 is a lateral view of the drug delivery device 1 prior to an injection. The outer body 3 is fully extended in the proximal direction P from the support body 2. The needle shield 4 is fully extended from the support body 2 in the distal direction D. The injection needle 6 is in a retracted position within the needle shield 4. The needle shield spring 9 is relaxed. In this situation the inward protrusion 4.7 is located distally from the distal inclined section 2.3.1 of the guiding track 2.3 so that the resilient retaining clips 4.5 are also relaxed.

(20) A user may grab the outer body 3 and push the proximal end of the needle shield 6 against an injection site, e.g. a patient's skin. The force from the user's hand is resolved through the outer body 3, the resilient snap arm 2.6, the support body 2, the inclined section 2.3.1 of the guiding track 2.3 and the retaining clips 4.5 into the needle shield 4. The retaining clips 4.5 engaging the inclined section 2.3.1 of the guiding track 2.3 provide a second detent force which has to be overcome in order to move the needle shield 4 against the support body 2. As the user applies a sufficiently high force exceeding the second detent force the needle shield 4 is moved in the proximal direction P with respect to the support body 2 and all other parts of the drug delivery device 1 thereby also compressing the needle shield spring 9 so that the drug delivery device 1 arrives in a state as illustrated in FIG. 8. At the same time, the retaining clips 4.5 are deflected in a first tangential direction T1 by the inclined section 2.3.1 and the inward protrusions 4.7 travel up the longitudinal section 2.3.2 in the proximal direction P. Once the inward protrusion 4.7 has travelled proximally beyond the longitudinal section 2.3.2 the retaining clips 4.5 are no longer deflected. Hence, they will relax into a position proximally from the proximal inclined section 2.3.3 so the inward protrusion 4.7 is prevented from travelling the same way back on subsequent extension of the needle shield 4. The first detent force is greater than the sum of the second detent force and the counteracting force of the needle shield spring 9 at full depression of the needle shield 4 such that on application of the drug delivery device 1 against the patient's skin the needle shield 4 always moves prior to the outer body 3 relative to the support body 2. This movement is opposed by the friction force of the injection needle 6 when penetrating the skin. In order to avoid a so called wet injection with drug leaking out of the tip of the needle during needle insertion before reaching the insertion depth the friction force of the needle 6 must be less than the counteracting force of the stopper 7 due to friction between the stopper 7 and the inner wall of the syringe 5 and due to the hydrostatic resistance of the drug to be displaced through the hollow needle 6, which depends on the inner diameter of the needle 6 and the viscosity of the drug. The needle insertion depth is defined by the needle shield 4 abutting the indicator ring 2.2. The mating surfaces of the indicator ring 2.2 and the needle shield 4 visually and haptically indicate to the user that they are intended to be pushed completely together in order to correctly apply the drug delivery device 1.

(21) Once insertion depth has been reached, further application of force onto the outer body 3 in excess of the first detent force results in deformation of the resilient snap arms 2.6 so that the outer body 3 decouples from the support body 2 and moves relative to the support body 2 in the distal direction D thus also moving the stopper 7 within the syringe barrel 5 so that the drug is displaced from the cavity through the injection needle 6. Near the end of the injection the stopper 7 bottoms out in the syringe barrel 5. At the same time the outer body 3 abuts the indicator ring 2.2 so that the drug delivery device 1 arrives in a state as illustrated in FIG. 9. The mating surfaces of the indicator ring 2.2 and the outer body 3 visually and haptically indicate to the user that they are intended to be pushed completely together in order to correctly apply the drug delivery device 1.

(22) If the user removes the drug delivery device 1 from the injection site the needle shield 4 is no longer pushed against the skin and is hence extended in the distal direction D relative to the other components of the drug delivery device 1 by the needle shield spring 9 such that the injection needle 6 arrives fully inside the needle shield 4 as illustrated in FIG. 10. During this movement the inward protrusion 4.7 engages the proximal inclined section 2.3.3 and is deflected in a second tangential direction T2 opposed to the first tangential direction T1. Once the inward protrusion 4.7 has travelled distally beyond the proximal inclined section 2.3.3 the retaining clips 4.5 are no longer deflected. Hence, they will relax into the catch 2.3.4 thus locking the needle shield 4 in position relative to the support body 2. The inward protrusion 4.7 and the retaining clips 4.5 are neither accessible for the user nor can they be deflected out of the catch 2.3.4 in any other way. Hence, the needle shield 4 is prevented from being depressed once more without destroying the drug delivery device 1.

(23) The end of the outer body 3 coupled to the support body 2 may comprise a radially outwards directed flange 3.6 thus improving ergonomics when applying the drug delivery device 1.

(24) In an exemplary embodiment a direction indicator 3.7 designed as a profiled cavity or concavity in the surface of the outer body 3 is arranged in the range of the flange 3.6.

(25) The needle shield 4 may likewise comprise a direction indicator 4.6.

(26) A label retaining recess 3.8 may be arranged in the outer body 3 for receiving a label which may be customized to the drug to be delivered and/or to the provider of the drug.

(27) FIG. 11 is a schematic view of the drug delivery device 1 with a boot remover 10 for removing the protective needle boot prior to an injection. The boot remover 10 may be arranged to engage the needle boot by friction or by means of barbs. The boot remover 10 comprises a handle extending from the opening 4.3 for facilitating boot removal. A direction indicator 10.1 may be provided on the boot remover 10 for indicating the direction in which the user has to move the boot remover 10 for removing the protective needle boot.